| Literature DB >> 34960672 |
Wei Wang1,2,3,4, Jizong Li1,2,3,4, Baochao Fan1,2,3,4, Xuehan Zhang1,2,3,4, Rongli Guo1,2,3,4, Yongxiang Zhao1,2,3,4, Junming Zhou1,2,3,4, Jinzhu Zhou1,2,3,4, Dongbo Sun5, Bin Li1,2,3,4.
Abstract
Porcine deltacoronavirus (PDCoV) can cause diarrhea and dehydration in newborn piglets. Here, we developed a double antibody sandwich quantitative enzyme-linked immunosorbent assay (DAS-ELISA) for detection of PDCoV by using a specific monoclonal antibody against the PDCoV N protein and an anti-PDCoV rabbit polyclonal antibody. Using DAS-ELISA, the detection limit of recombinant PDCoV N protein and virus titer were approximately 0.5 ng/mL and 103.0 TCID50/mL, respectively. A total of 59 intestinal and 205 fecal samples were screened for the presence of PDCoV by using DAS-ELISA and reverse transcriptase real-time PCR (RT-qPCR). The coincidence rate of the DAS-ELISA and RT-qPCR was 89.8%. DAS-ELISA had a sensitivity of 80.8% and specificity of 95.6%. More importantly, the DAS-ELISA could detect the antigen of PDCoV inactivated virus, and the viral antigen concentrations remained unchanged in the inactivated virus. These results suggest that DAS-ELISA could be used for antigen detection of clinical samples and inactivated vaccines. It is a novel method for detecting PDCoV infections and evaluating the PDCoV vaccine.Entities:
Keywords: antigen detection; intestinal and fecal samples; porcine deltacoronavirus; quantitative ELISA; vaccine evaluation
Mesh:
Substances:
Year: 2021 PMID: 34960672 PMCID: PMC8703818 DOI: 10.3390/v13122403
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Figure 1Expression and purification of the recombinant PDCoV-N protein. (A) SDS-PAGE of the whole lysate of transfected E. coli BL21(DE3); M-MW markers, 1—without induction, 2—IPTG induction. (B) SDS-PAGE of supernatant and pellet of the cell lysate; M-MW markers, 3—supernatant sample, 4—pellet sample. (C) SDS-PAGE of rPDCoV-N protein after purification; M-MW markers, 5—the purified rPDCoV-N protein. (D) Western blot of the purified rPDCoV-N protein; M-MW markers, 1—the purified rPDCoV-N protein, 2—the whole cell lysate without induction.
The antibody titers of 12 mAbs.
| Antibody Titers | Numbers of mAb |
|---|---|
| >1:1,024,000 | 2 |
| 1:1,024,000 | 3 |
| 1:25,600 | 6 |
| 1:9000 | 1 |
The antibody subtypes of 12 mAbs.
| Antibody Subtypes | Numbers of mAb |
|---|---|
| IgG1 | 1 |
| IgG2a | 5 |
| IgG2b | 5 |
| IgM | 1 |
The selection of pairing antibodies.
| mAbs No. | OD450–630 Value | |||
|---|---|---|---|---|
| rPDCoV-N Protein (50 ng/mL) | PBS Control | PDCoV-CZ2020 Virus | LLC-PK1 Control | |
| 1# | 1.288 | 0.074 | 0.4662 | 0.287 |
| 2# | 2.267 | 0.084 | 3.3586 | 0.124 |
| 3# | 1.414 | 0.231 | 1.8031 | 0.207 |
| 4# | 1.697 | 0.073 | 2.5677 | 0.083 |
| 5# | 1.519 | 0.063 | 0.1095 | 0.061 |
| 6# | 1.482 | 0.068 | 2.8471 | 0.063 |
| 7# | 1.625 | 0.062 | 2.0744 | 0.072 |
| 8# | 1.436 | 0.049 | 2.5737 | 0.147 |
| 9# | 1.547 | 0.119 | 1.7631 | 0.062 |
| 10# | 1.537 | 0.061 | 1.8848 | 0.074 |
| 11# | 1.364 | 0.114 | 0.9269 | 0.287 |
| 12# | 1.558 | 0.095 | 2.4024 | 0.124 |
The results of specificity assay.
| Virus | PDCoV | PEDV | TGEV | PoRV | PRRSV | PCV2 | CSFV | PRV |
|---|---|---|---|---|---|---|---|---|
| OD450–630 value | 1.957 | 0.037 | 0.046 | 0.039 | 0.026 | 0.03 | 0.032 | 0.033 |
| PDCoV-N concentration (ng/mL) | 5.50 | −0.24 | −0.21 | −0.23 | −0.27 | −0.26 | −0.25 | −0.25 |
The results of standard rPDCoV-N protein by using a DAS-ELISA kit.
| rPDCoV-N Protein (ng/mL) | OD450–630 Value | |
|---|---|---|
| Repeat 1 | Repeat 2 | |
| 8 | 2.725 | 2.823 |
| 4 | 1.424 | 1.485 |
| 2 | 0.884 | 0.857 |
| 1 | 0.543 | 0.481 |
| 0.5 | 0.246 | 0.274 |
| 0.25 | 0.122 | 0.119 |
| 0 | 0.025 | 0.024 |
Figure 2The standard curve of the DAS-ELISA. Two-fold serially diluted standard rPDCoV-N protein concentrations of 8, 4, 2, 1, 0.5, and 0 ng/mL were assayed using DAS-ELISA with two replicates per concentration. The standard curve was calculated using a linear relationship between the OD450–630 values and concentrations.
The results of PDCoV virus by using a DAS-ELISA kit.
| Dilution Fold of Virus | Virus Titer (TCID50/mL) | OD450–630 Value | Concentration (ng/mL) |
|---|---|---|---|
| 1:10 | 105.0 | 3.314 | exceed the test limit |
| 1:20 | 104.7 | 3.070 | exceed the test limit |
| 1:40 | 104.4 | 2.452 | 6.99 |
| 1:80 | 104.1 | 1.609 | 4.42 |
| 1:160 | 103.8 | 0.949 | 2.41 |
| 1:320 | 103.5 | 0.567 | 1.25 |
| 1:640 | 103.2 | 0.325 | 0.51 |
| 1:1280 | 102.9 | 0.209 | 0.16 |
| 1:2560 | 102.6 | 0.134 | −0.07 |
| Negative control | 0 | 0.083 | −0.229 |
The results of intra-batch duplicability test.
| Assay Time | No. of PDCoV Positive Fecal Samples | ||||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 174 | 187 | 196 | |
| First | 8.27 | 5.48 | 4.03 | 2.48 | 1.97 | 2.40 | 2.08 |
| Second | 8.39 | 5.01 | 3.85 | 2.56 | 1.77 | 2.66 | 1.89 |
| Third | 8.40 | 4.62 | 3.98 | 2.48 | 1.70 | 2.73 | 1.75 |
| X | 8.35 | 5.04 | 3.95 | 2.51 | 1.81 | 2.60 | 1.91 |
| SD | 0.06 | 0.35 | 0.08 | 0.03 | 0.12 | 0.14 | 0.13 |
| CV | 0.67% | 7.01% | 1.95% | 1.38% | 6.40% | 5.36% | 7.03% |
The results of inter-batch duplicability test.
| Assay Time | No. of PDCoV Positive Fecal Samples | ||||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 174 | 187 | 196 | |
| First | 8.84 | 5.82 | 4.57 | 2.70 | 1.78 | 2.70 | 1.61 |
| Second | 8.69 | 5.35 | 4.70 | 2.49 | 1.68 | 2.48 | 1.61 |
| Third | 8.54 | 5.36 | 4.29 | 2.64 | 1.63 | 2.39 | 1.47 |
| X | 8.69 | 5.51 | 4.52 | 2.61 | 1.70 | 2.52 | 1.56 |
| SD | 0.12 | 0.22 | 0.17 | 0.09 | 0.06 | 0.13 | 0.06 |
| CV | 1.43% | 4.03% | 3.81% | 3.35% | 3.65% | 5.16% | 4.04% |
Comparison of RT-qPCR and DAS-ELISA for the detection of PDCoV in intestinal and fecal samples.
| DAS-ELISA | ||||
|---|---|---|---|---|
| RT-qPCR | Fecal | Positive | Negative | Total |
| Positive | 73 | 14 | 87 | |
| Negative | 5 | 113 | 118 | |
| Total | 78 | 127 | 205 | |
| Intestinal | Positive | Negative | Total | |
| Positive | 11 | 6 | 17 | |
| Negative | 2 | 40 | 42 | |
| Total | 13 | 46 | 59 | |
Detection of live and inactivated viruses.
| Dilutability | Live Virus | Inactivated Virus | ||||
|---|---|---|---|---|---|---|
| OD450–630 Value | Concentration | Final Concentration | OD450–630 Value | Concentration | Final Concentration | |
| (ng/mL) | (ng/mL) | (ng/mL) | (ng/mL) | |||
| 10 | 3.313 | exceed the test limit | / | 3.306 | exceed the test limit | / |
| 100 | 3.3 | exceed the test limit | / | 3.32 | exceed the test limit | / |
| 1000 | 2.444 | 6.95 | 20,398 | 2.495 | 7.10 | 20,852 |
| 2000 | 1.778 | 4.96 | 28,927 | 1.51 | 4.16 | 24,150 |
| 4000 | 1.161 | 3.12 | 35,862 | 0.907 | 2.36 | 26,808 |
| 8000 | 0.623 | 1.51 | 33,372 | 0.507 | 1.17 | 25,102 |